Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.700
+0.080 (1.73%)
Jul 9, 2026, 2:01 PM EDT - Market open
Minerva Neurosciences Employees
Minerva Neurosciences had 7 employees as of December 31, 2025. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$59,296,370
Market Cap
218.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | -1 | -12.50% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | -2 | -18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Karyopharm Therapeutics | 228 |
| Voyager Therapeutics | 141 |
| Nautilus Biotechnology | 127 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Keros Therapeutics | 87 |
| Compugen | 75 |
NERV News
- 4 weeks ago - Minerva Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Minerva Neurosciences Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Slides: Corporate presentation - Filings
- 7 weeks ago - Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Earnings release: Q1 2026 - Filings
- 2 months ago - Minerva Neurosciences Quarterly report: Q1 2026 - Filings